CA2870823C - A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome) - Google Patents
A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome) Download PDFInfo
- Publication number
- CA2870823C CA2870823C CA2870823A CA2870823A CA2870823C CA 2870823 C CA2870823 C CA 2870823C CA 2870823 A CA2870823 A CA 2870823A CA 2870823 A CA2870823 A CA 2870823A CA 2870823 C CA2870823 C CA 2870823C
- Authority
- CA
- Canada
- Prior art keywords
- bone
- cavities
- osteoporosis
- vitamin
- metabolic syndrome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Insects & Arthropods (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2012115654/15A RU2497533C1 (ru) | 2012-04-19 | 2012-04-19 | Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме) |
| RU2012115654 | 2012-04-19 | ||
| PCT/RU2012/000687 WO2013157982A1 (ru) | 2012-04-19 | 2012-08-21 | Препарат и способ профилактики и лечения атипичного остеопороза |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2870823A1 CA2870823A1 (en) | 2013-10-24 |
| CA2870823C true CA2870823C (en) | 2017-10-03 |
Family
ID=49383800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2870823A Active CA2870823C (en) | 2012-04-19 | 2012-08-21 | A method for preventing and treating atypical osteoporosis with normal or increased bone tissue mineralizarion with the presence of cavities in trabecular sections of bone (and conditions similar thereto involving excess mass and metabolic syndrome) |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US9827273B2 (enExample) |
| EP (1) | EP2845598B1 (enExample) |
| JP (1) | JP6286417B2 (enExample) |
| CN (1) | CN104736161B (enExample) |
| AU (1) | AU2012377476B2 (enExample) |
| BR (1) | BR112014025990B1 (enExample) |
| CA (1) | CA2870823C (enExample) |
| DK (1) | DK2845598T3 (enExample) |
| EA (1) | EA026533B1 (enExample) |
| ES (1) | ES2616035T3 (enExample) |
| IL (1) | IL235169B (enExample) |
| IN (1) | IN2014DN09780A (enExample) |
| LT (1) | LT2845598T (enExample) |
| PL (1) | PL2845598T3 (enExample) |
| RU (1) | RU2497533C1 (enExample) |
| UA (1) | UA111536C2 (enExample) |
| WO (1) | WO2013157982A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180249751A1 (en) * | 2009-11-30 | 2018-09-06 | Parapharm Llc | Preparation for Treating Androgen Deficiency in Women |
| US20190381072A1 (en) * | 2012-04-19 | 2019-12-19 | Parapharm Llc | Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis |
| RU2498811C1 (ru) * | 2012-04-19 | 2013-11-20 | Общество С Ограниченной Ответственностью "Парафарм" | Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей |
| RU2564111C9 (ru) * | 2013-07-03 | 2016-03-20 | Общество С Ограниченной Ответственностью "Парафарм" | Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа |
| RU2577225C1 (ru) * | 2015-03-27 | 2016-03-10 | Общество С Ограниченной Ответственностью "Парафарм" | Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины |
| WO2022220520A1 (ko) * | 2021-04-13 | 2022-10-20 | 삼성전자주식회사 | 조리 장치 및 이의 제어 방법 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1101684C (zh) * | 1997-07-24 | 2003-02-19 | 薛大权 | 蜂蛹钙制剂 |
| CA2526845A1 (en) * | 2003-06-06 | 2005-03-31 | Wyeth | Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby |
| AU2009214052B2 (en) * | 2008-02-13 | 2015-05-07 | Dsm Ip Assets B.V. | Combined use of 25-hydroxy-vitamin D3 and vitamin D3 for improving bone mineral density and for treating osteoporosis |
| RU2412616C1 (ru) * | 2009-11-30 | 2011-02-27 | Общество С Ограниченной Ответственностью "Парафарм" | Биологически активная добавка к пище для профилактики заболеваний остеопорозом |
-
2012
- 2012-04-19 RU RU2012115654/15A patent/RU2497533C1/ru active
- 2012-08-21 ES ES12874454.7T patent/ES2616035T3/es active Active
- 2012-08-21 JP JP2015506933A patent/JP6286417B2/ja not_active Expired - Fee Related
- 2012-08-21 PL PL12874454T patent/PL2845598T3/pl unknown
- 2012-08-21 UA UAA201412408A patent/UA111536C2/uk unknown
- 2012-08-21 LT LTEP12874454.7T patent/LT2845598T/lt unknown
- 2012-08-21 BR BR112014025990-9A patent/BR112014025990B1/pt active IP Right Grant
- 2012-08-21 EA EA201401155A patent/EA026533B1/ru unknown
- 2012-08-21 CA CA2870823A patent/CA2870823C/en active Active
- 2012-08-21 CN CN201280074021.7A patent/CN104736161B/zh active Active
- 2012-08-21 DK DK12874454.7T patent/DK2845598T3/en active
- 2012-08-21 WO PCT/RU2012/000687 patent/WO2013157982A1/ru not_active Ceased
- 2012-08-21 EP EP12874454.7A patent/EP2845598B1/en active Active
- 2012-08-21 US US14/395,478 patent/US9827273B2/en active Active
- 2012-08-21 AU AU2012377476A patent/AU2012377476B2/en not_active Ceased
-
2014
- 2014-10-19 IL IL23516914A patent/IL235169B/en active IP Right Grant
- 2014-11-19 IN IN9780DEN2014 patent/IN2014DN09780A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201401155A1 (ru) | 2015-05-29 |
| UA111536C2 (uk) | 2016-05-10 |
| IL235169B (en) | 2019-10-31 |
| US20150224150A1 (en) | 2015-08-13 |
| US9827273B2 (en) | 2017-11-28 |
| EP2845598A1 (en) | 2015-03-11 |
| PL2845598T3 (pl) | 2017-07-31 |
| JP2015516974A (ja) | 2015-06-18 |
| IL235169A0 (en) | 2014-12-31 |
| RU2497533C1 (ru) | 2013-11-10 |
| WO2013157982A1 (ru) | 2013-10-24 |
| CN104736161B (zh) | 2021-07-06 |
| EA026533B1 (ru) | 2017-04-28 |
| AU2012377476A8 (en) | 2014-12-18 |
| CA2870823A1 (en) | 2013-10-24 |
| JP6286417B2 (ja) | 2018-02-28 |
| LT2845598T (lt) | 2017-02-27 |
| BR112014025990A2 (pt) | 2017-06-27 |
| ES2616035T3 (es) | 2017-06-09 |
| EP2845598A4 (en) | 2015-10-28 |
| CN104736161A (zh) | 2015-06-24 |
| AU2012377476A1 (en) | 2014-12-11 |
| BR112014025990B1 (pt) | 2021-02-17 |
| IN2014DN09780A (enExample) | 2015-07-31 |
| DK2845598T3 (en) | 2017-04-10 |
| AU2012377476B2 (en) | 2017-10-05 |
| EP2845598B1 (en) | 2017-01-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2012377476B2 (en) | Preparation and method for the prophylaxis and treatment of atypical osteoporosis | |
| JP2015516974A5 (ja) | 骨の線維柱帯における空洞病巣発生を有する正常又は増加した骨組織石灰化に伴う非定型骨粗鬆症を対象にする予防または治療剤 | |
| AU2012377478B2 (en) | Preparation and method for the prophylaxis and treatment of osteoporosis and bone fractures | |
| AU2017203767B2 (en) | Method for filling bone cavity formations with calcium | |
| BR112017007364B1 (pt) | Composições farmacêuticas e usos das mesmas para o tratamento ou prevenção de deficiências de vitaminas e minerais em pacientes submetidos à cirurgia de bypass gástrico | |
| Goel et al. | Role of L arginine in treatment of osteoporosis | |
| US20190381072A1 (en) | Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis | |
| EA028560B1 (ru) | Способ и препарат для лечения артритов и артрозов | |
| NZ619215B2 (en) | Method for filling bone cavities with calcium |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20151215 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 12TH ANNIV.) - STANDARD Year of fee payment: 12 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20240910 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20240910 Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20240910 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 13TH ANNIV.) - STANDARD Year of fee payment: 13 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250811 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250902 |
|
| MPN | Maintenance fee for patent paid |
Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 14TH ANNIV.) - STANDARD Year of fee payment: 14 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260629 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260629 |